ASGRCi004-A

0118 CHR

General

Cell Line

hPSCreg name ASGRCi004-A
Cite as:
ASGRCi004-A (RRID:CVCL_YB78)
Alternative name(s)
0118 CHR
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
ASGRCi007-A
(T2D19#2 XY-CHR)
Donor diseases:
type 2 diabetes mellitus
CIRMi471-A
(CW70276)
Donor diseases:
type 2 diabetes mellitus
CIRMi472-A
(CW70278)
Donor diseases:
type 2 diabetes mellitus
CIRMi473-A
(CW70279)
Donor diseases:
type 2 diabetes mellitus
CIRMi357-A
(CW70124)
Donor diseases:
type 2 diabetes mellitus
CIRMi485-A
(CW70297)
Donor diseases:
type 2 diabetes mellitus
CIRMi487-A
(CW70299)
Donor diseases:
type 2 diabetes mellitus
CIRMi152-A
(CW50068)
Donor diseases:
type 2 diabetes mellitus
CIRMi493-A
(CW70306)
Donor diseases:
type 2 diabetes mellitus
CIRMi494-A
(CW70307)
Donor diseases:
type 2 diabetes mellitus
CIRMi497-A
(CW70310)
Donor diseases:
type 2 diabetes mellitus
CIRMi379-A
(CW70158)
Donor diseases:
type 2 diabetes mellitus
CIRMi386-A
(CW70170)
Donor diseases:
type 2 diabetes mellitus
CIRMi387-A
(CW70171)
Donor diseases:
type 2 diabetes mellitus
CIRMi515-A
(CW70337)
Donor diseases:
type 2 diabetes mellitus
CIRMi518-A
(CW70341)
Donor diseases:
type 2 diabetes mellitus
CIRMi522-A
(CW70345)
Donor diseases:
type 2 diabetes mellitus
CIRMi183-A
(CW50118)
Donor diseases:
type 2 diabetes mellitus
CIRMi268-A
(CW70002)
Donor diseases:
type 2 diabetes mellitus
CIRMi527-A
(CW70351)
Donor diseases:
type 2 diabetes mellitus
CIRMi529-A
(CW70354)
Donor diseases:
type 2 diabetes mellitus
CIRMi533-A
(CW70359)
Donor diseases:
type 2 diabetes mellitus
CIRMi280-A
(CW70016)
Donor diseases:
type 2 diabetes mellitus
CIRMi535-A
(CW70364)
Donor diseases:
type 2 diabetes mellitus
CIRMi414-A
(CW70201)
Donor diseases:
type 2 diabetes mellitus
CIRMi289-A
(CW70032)
Donor diseases:
type 2 diabetes mellitus
CIRMi290-A
(CW70033)
Donor diseases:
type 2 diabetes mellitus
CIRMi301-A
(CW70044)
Donor diseases:
type 2 diabetes mellitus
CIRMi303-A
(CW70047)
Donor diseases:
type 2 diabetes mellitus
CIRMi304-A
(CW70048)
Donor diseases:
type 2 diabetes mellitus
CIRMi306-A
(CW70050)
Donor diseases:
type 2 diabetes mellitus
CIRMi309-A
(CW70057)
Donor diseases:
type 2 diabetes mellitus
CIRMi437-A
(CW70235)
Donor diseases:
type 2 diabetes mellitus
CIRMi438-A
(CW70239)
Donor diseases:
type 2 diabetes mellitus
CIRMi458-A
(CW70261)
Donor diseases:
type 2 diabetes mellitus
CIRMi337-A
(CW70101)
Donor diseases:
type 2 diabetes mellitus
CIRMi466-A
(CW70270)
Donor diseases:
type 2 diabetes mellitus
CIRMi467-A
(CW70272)
Donor diseases:
type 2 diabetes mellitus
CIRMi470-A
(CW70275)
Donor diseases:
type 2 diabetes mellitus
CIRMi475-A
(CW70281)
Donor diseases:
type 2 diabetes mellitus
CIRMi136-A
(CW50050)
Donor diseases:
type 2 diabetes mellitus
CIRMi477-A
(CW70283)
Donor diseases:
type 2 diabetes mellitus
CIRMi478-A
(CW70284)
Donor diseases:
type 2 diabetes mellitus
CIRMi486-A
(CW70298)
Donor diseases:
type 2 diabetes mellitus
CIRMi490-A
(CW70303)
Donor diseases:
type 2 diabetes mellitus
CIRMi491-A
(CW70304)
Donor diseases:
type 2 diabetes mellitus
CIRMi495-A
(CW70308)
Donor diseases:
type 2 diabetes mellitus
CIRMi500-A
(CW70315)
Donor diseases:
type 2 diabetes mellitus
Last update 30th October 2019
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Genomics Research Center (ASGRC)

External Databases

BioSamples SAMEA6285361
Cellosaurus CVCL_YB78
Wikidata Q93326120

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex female

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Synonyms
  • proliferative diabetic retinopathy
  • PDR
Synonyms
  • NIDDM
  • non-insulin-dependent diabetes mellitus
  • type 2 diabetes
  • type II diabetes mellitus
show more synonyms

External Databases (Donor)

BioSamples SAMEA6285362

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? Yes
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Institutional Review Board of Taichung Veterans General Hospital
Approval number CE16081B
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
  • PERIPHERAL BLOOD MONONUCLEAR CELL
  • Peripheral Blood Mononuclear Cell
  • PBMC

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Genes
Is reprogramming vector detectable?
No
Methods used
RT-PCR
Notes on reprogramming vector detection RT-PCR conducted to confirm the absence of Sendai virus
Files and images showing reprogramming vector expressed or silenced

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
CO2 Concentration 5 %
Medium Essential 8™
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
No

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
POU5F1 (OCT-4)
Yes
SOX2
Yes
SSEA-4
Yes
Morphology pictures
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vivo teratoma
Cartilage Element
Ont Id: UBERON_0007844
In vivo teratoma
Ectoderm
Ont Id: UBERON_0000924
In vivo teratoma

Microbiology / Virus Screening

Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
karyogram
Karyotyping method: G-Banding

Other Genotyping (Cell Line)